Efficacy of Texture and Color Enhancement Imaging for esophagogastroduodenoscopy

Efficacy of Texture and Color Enhancement Imaging for esophagogastroduodenoscopy - TXI for EGD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045323

Enrollment

Registered

2021-09-01

Start date

2021-02-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the Kyoto Classification of Gastritis, Laryngitis, lesions of the gastroesophageal junction, vascular lesion, neoplastic lesion, autoimmune gastritis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with gastrointestinal lesions who underwent esophagogastroduodenoscopy with TXI and WLI.

Exclusion criteria

Exclusion criteria: Patients who had a history of gastrectomy or esophageal surgery, and patients for whom endoscopic examination was considered difficult because of serious hepatic, heart, or respiratory diseases.

Design outcomes

Primary

Measure	Time frame
Evaluation of visibility between WLI and TXI in upper GI lesions.	—

Secondary

Measure	Time frame
Evaluation of diagnostic ability and color difference with TXI in upper GI lesions.	—

Countries

Japan

Contacts

Public ContactTsutomu Takeda

Juntendo University school of Medicine Department of Gastroenterology

t-takeda@juntendo.ac.jp0338133111

Outcome results